DNA
Insight | Legal Alert

Life Sciences Collaborations: Key Considerations in the COVID-19 Era

We present some key considerations that companies in the sector need to bear in mind to cope with the growing complexities of licensing and collaboration agreements.
Read More

We are one of the world’s most active law firms in the pharmaceutical, biotech and medical device spaces. Our extensive geographic footprint, coupled with a single point of contact, makes us the go-to law firm for various global matters. Our life sciences transactions team has significant experience in the following areas:

Collaborations and Licensing

  • Complex multinational collaborations
  • Joint ventures
  • Commercialization agreements
  • Co-promotion agreements
  • Research and development agreements
  • Evaluation and option agreements

M&A

  • Product acquisitions and divestitures
  • Company sales and acquisitions
  • Business unit spinoffs
  • Post-acquisition integration

Financings

  • Equity financing
  • Royalty monetization
  • Development funding agreements

Operational Agreements

  • Manufacturing and supply agreements
  • Distribution agreements
  • Services agreements
  • University and other nonprofit agreements